Efficacy of continuous positive airway pressure on subcutaneous adipose tissue in patients with obstructive sleep apnea: a meta-analysis of randomized controlled trials

[1] Sharma RA(2018)Obstructive sleep apnea severity affects amyloid burden in cognitively normal elderly. A longitudinal study Am J Respir Crit Care Med 197 933-943

[2] Varga AW(2019)Unique sleep-stage transitions determined by obstructive sleep apnea severity, age and gender J Sleep Res 29 e12895-219

[3] Bubu OM(2018)Obstructive sleep apnea and the metabolic syndrome: the road to clinically-meaningful phenotyping, improved prognosis, and personalized treatment Sleep Med Rev 42 211-1019

[4] Pirraglia E(2019)The association between obstructive sleep apnea syndrome and metabolic syndrome: a confirmatory factor analysis Sleep Breath 23 1011-414

[5] Kam K(2017)Screening for obstructive sleep apnea in adults: US preventive services task force recommendation statement JAMA 317 407-331

[6] Parekh A(2009)Obstructive sleep apnea/hypopnea and systemic hypertension Sleep Med Rev 13 323-698

[7] Wohlleber M(2019)Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis Lancet Respir Med 7 687-576

[8] Miller MD(2013)Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome J Am Coll Cardiol 62 569-1026

[9] Andrade A(2014)Regulation of human subcutaneous adipose tissue blood flow Int J Obes 38 1019-719

[10] Lewis C(2010)Interactions between obesity and obstructive sleep apnea: implications for treatment CHEST 137 711-48

[1] Sharma RA(2018)Obstructive sleep apnea severity affects amyloid burden in cognitively normal elderly. A longitudinal study Am J Respir Crit Care Med 197 933-943

[2] Varga AW(2019)Unique sleep-stage transitions determined by obstructive sleep apnea severity, age and gender J Sleep Res 29 e12895-219

[3] Bubu OM(2018)Obstructive sleep apnea and the metabolic syndrome: the road to clinically-meaningful phenotyping, improved prognosis, and personalized treatment Sleep Med Rev 42 211-1019

[4] Pirraglia E(2019)The association between obstructive sleep apnea syndrome and metabolic syndrome: a confirmatory factor analysis Sleep Breath 23 1011-414

[5] Kam K(2017)Screening for obstructive sleep apnea in adults: US preventive services task force recommendation statement JAMA 317 407-331

[6] Parekh A(2009)Obstructive sleep apnea/hypopnea and systemic hypertension Sleep Med Rev 13 323-698

[7] Wohlleber M(2019)Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis Lancet Respir Med 7 687-576

[8] Miller MD(2013)Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome J Am Coll Cardiol 62 569-1026

[9] Andrade A(2014)Regulation of human subcutaneous adipose tissue blood flow Int J Obes 38 1019-719

[10] Lewis C(2010)Interactions between obesity and obstructive sleep apnea: implications for treatment CHEST 137 711-48